header-medias

Events

4th GBM Drug Development Summit

At the 4th GBM Drug Development Summit, Louis-Marie Bachelot, CEO and cofounder of GlioCure, will...

GlioCure in the OUI Pitch selection of Oncology Partnering Convention Meet2Win 2019

GlioCure has been selected by a committee of twelve investors (ADVENT France Biotechnology,...

GlioCure selected at the 3rd International Biotechnology Meetings and FTTI 2018

After its participation on February 7, 2018 in the 3rd International Biotechnology Meetings...

GLIOCURE IN THE SELECTION OF THE 10 START-UPS OF THE PHDTALENT CAREER FAIR 2017

GlioCure was selected along with nine other start-ups for a quick presentation at the PhDTalent...

Presentation of Gliocure at VIVA Technology Paris 2017

GlioCure will be present at VIVA Technology Paris 2017 at the invitation of the Technology...

Presentation of GC01 at the MATWIN INTERNATIONAL BOARD 2017

GlioCure will participate for the 2nd consecutive year in the business convention entirely...

Gliocure selected for France Tech Transfer Invest (FTTI)

GlioCure is one of ten biotech start-ups selected by a panel of European investors to participate...

Initiative-Anjou accompanies the creation of gliocure

Support of Initiative-Anjou to the founders of GlioCure by the granting of a loan of honor of...

Pays-de-la-Loire territories of innovation supports the Gliocure project

The GlioCure project receives a Territorial Innovation grant of € 7,000 from the...

GlioCure labeled French Tech Emergence by BPI

The GlioCure team receives from BPI a French Tech Emergence grant of € 42,000 for the...

Meet2Win selects GlioCure for "elevator pitch"

Selection at the elevator pitch of the Meet2Win oncology business convention
See the publication

Gliocure is selected at starwest 2016

The GlioCure project is selected for an investor presentation at StartWest 2016
See the publication